As of 3:59pm ET
| +0.23 / +3.29%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 12.08, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +67.30% increase from the last price of 7.22.
The current consensus among 6 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.